[Discontinuation or tapering strategies of biologics in rheumatoid arthritis in remission]
Clicks: 412
ID: 117028
2017
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
412 views
36 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #1 of 11 articles by views in la revue de medecine interne
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The arrival of new drugs and new therapeutic strategies allowed to reach sustained remission in an increasing number of patients with rheumatoid arthritis. The study of biologic disease-modifying anti-rheumatic drugs (bDMARDs) adaptation strategies is a need to optimize the benefit/risk balance and …
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (43 words).
Try re-searching for a better abstract.
| Reference Key |
a2017la[discontinuation
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Mallick A;Fautrel B;Sagez F;Sordet C;Javier RM;Petit H;Chatelus E;Rahal N;Gottenberg JE;Sibilia J;; |
| Journal | la revue de medecine interne |
| Year | 2017 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
humans
pubmed abstract
nih
national institutes of health
national library of medicine
Recurrence
Remission Induction
dose-response relationship
drug
arthritis
rheumatoid / drug therapy*
practice patterns
antirheumatic agents / administration & dosage*
pmid:28161110
doi:10.1016/j.revmed.2016.12.014
a mallick
b fautrel
j sibilia
biological factors / administration & dosage
biological products / administration & dosage*
physicians'
withholding treatment* / standards
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.